119 related articles for article (PubMed ID: 4018373)
1. Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma.
Bast RC; Knapp RC
Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):354-6. PubMed ID: 4018373
[No Abstract] [Full Text] [Related]
2. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
3. Antigens associated with epithelial ovarian carcinomas.
Bast RC
Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
[No Abstract] [Full Text] [Related]
4. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
Bar J; Sobańska E
Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer: immunologic diagnosis and therapy.
Barber HR; Dorsett B
Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
[No Abstract] [Full Text] [Related]
6. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ; Cordon-Cardo C; Lewis JL; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):568-72. PubMed ID: 6582512
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cytodiagnosis of ovarian tumors employing monoclonal antibodies.
Natali PG; Mottolese M; Venturo I; Salzano M; Perrone Donnorso R; Bigotti A; Atlante G
Contrib Gynecol Obstet; 1991; 18():93-102. PubMed ID: 1935130
[No Abstract] [Full Text] [Related]
8. [Tumor antigens CA 125 and CA l9-9 in the serum of patients with gynecologic trophoblastic tumors and colorectal carcinoma].
Göcze P; Szabó D; Than G; Csaba I; Krommer K
Orv Hetil; 1986 Aug; 127(35):2123-6. PubMed ID: 3024089
[No Abstract] [Full Text] [Related]
9. [Characterization of two antigens OC41 D and OC41 E associated with ovarian carcinoma].
Cui H
Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):284-6, 314-5. PubMed ID: 8243148
[TBL] [Abstract][Full Text] [Related]
10. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
11. [The production and identification of OC859--a monoclonal antibody against tumor associated antigen in ovarian epithelial carcinoma].
Hu XF
Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):367-9, 388. PubMed ID: 3248430
[No Abstract] [Full Text] [Related]
12. Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours.
Boerman OC; Makkink WK; Thomas CM; Hanselaar AG; Yedema CA; Kenemans P; Poels LG
Eur J Cancer; 1990 Feb; 26(2):117-27. PubMed ID: 2138906
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
Chang K; Pastan I; Willingham MC
Int J Cancer; 1992 Feb; 50(3):373-81. PubMed ID: 1735605
[TBL] [Abstract][Full Text] [Related]
15. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
Bast RC; Klug TL; St John E; Jenison E; Niloff JM; Lazarus H; Berkowitz RS; Leavitt T; Griffiths CT; Parker L; Zurawski VR; Knapp RC
N Engl J Med; 1983 Oct; 309(15):883-7. PubMed ID: 6310399
[TBL] [Abstract][Full Text] [Related]
16. Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group.
Rustin GJ; Gennings JN; Nelstrop AE; Covarrubias H; Lambert HE; Bagshawe KD
J Clin Oncol; 1989 Nov; 7(11):1667-71. PubMed ID: 2681555
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinoma: increase in clinical validity by simultaneous determination of SRA and CA 125.
Schleich HG; Wiest W; Schmidt R; Hofmann I; Altenburg HP; Melchert F
J Cancer Res Clin Oncol; 1987; 113(6):603-7. PubMed ID: 3680367
[TBL] [Abstract][Full Text] [Related]
18. Digital necrosis and lupus-like syndrome preceding ovarian carcinoma.
Chtourou M; Aubin F; Savariault I; Chabot P; Manchet G; Montcuquet P; Humbert P
Dermatology; 1998; 196(3):348-9. PubMed ID: 9621147
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.
Kenemans P; Yedema CA; Hilgers JH; Massuger LF; Verheijen RH; Thomas CM; Poels LG
Eur J Obstet Gynecol Reprod Biol; 1988 Nov; 29(3):207-18. PubMed ID: 3065097
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
